Michelle Michels

Dr. Michelle Michels is a Researcher in the Department of Cardiology at Erasmus University Medical Center (Erasmus MC), Rotterdam, the Netherlands, specializing in inherited cardiac conditions with 191 research outputs including 181 articles. Her work centers on hypertrophic cardiomyopathy and related genetic heart diseases within Europe's leading cardiovascular research framework.

Her research spans hypertrophic cardiomyopathy, genetic myocardial disorders, and cardiac imaging, investigating genotype-negative disease expression, arrhythmia risks in RBM20-associated cases, and physical activity impacts through accelerometry. Current projects include the ENERGY clinical trial on trimetazidine therapy and European Reference Network initiatives for rare cardiomyopathy management, emphasizing multidisciplinary collaboration across 12 international profiles.

Recent publications reveal strong trends toward translational research integrating genetic profiling with clinical outcomes, particularly in pre-symptomatic disease stages and quality-of-life interventions. Her work consistently addresses therapeutic gaps in inherited heart conditions through multicenter cohort studies and randomized trials.

Scientific awards: No specific awards were documented in the source material.

Dr. Michels has supervised 4 students per institutional records and participates in major European collaborative networks including the European Reference Network for rare heart diseases. Her grant-funded work focuses on clinical trials like ENERGY and multinational studies on transition care for inherited cardiomyopathies.

Embedded within Erasmus MC's Cardiology department—a hub for genetic heart disease research—she collaborates extensively across European institutions as evidenced by co-authorship in high-impact journals and network visualizations showing country-level research partnerships.